Carol Ballard
Family · Blacksburg, VANPI 1437146818
Payments from drug & device makers
Across 338 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$753
- AbbVie$732
- Lilly USA, LLC$411
- Amgen$287
- Pfizer$278
- AstraZeneca$240
- plus $3K from 34 others
What the payments were for
- Food & beverage$5,24599%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $753 |
| AbbVie | 57 | $732 |
| Lilly USA, LLC | 28 | $411 |
| Amgen(2 entities) | 16 | $287 |
| Pfizer | 18 | $278 |
| AstraZeneca | 16 | $240 |
| Abbott | 16 | $217 |
| Mannkind Corporation | 15 | $197 |
| Bayer | 8 | $147 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $145 |
| Xeris Pharmaceuticals, Inc. | 7 | $138 |
| Boehringer Ingelheim | 6 | $118 |
| Sanofi-aventis U.S. LLC | 7 | $116 |
| Bausch Health US, LLC | 6 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| Johnson & Johnson | 7 | $100 |
| GSK | 6 | $90 |
| Merck | 5 | $88 |
| Biohaven Pharmaceuticals, Inc. | 4 | $87 |
| Novartis | 5 | $83 |
| Astellas Pharma US Inc | 5 | $79 |
| Esperion Therapeutics, Inc. | 3 | $68 |
| Dexcom, Inc. | 3 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| E.r. Squibb & Sons, L.L.C. | 4 | $62 |
| Exact Sciences | 3 | $58 |
| Biogen | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Nestle Healthcare Nutrition Inc. | 3 | $43 |
| BD | 1 | $43 |
| Corium, LLC | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $37 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
How this compares
$5,277 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $35,441 |
| JardianceEmpagliflozin | 14 | $18,244 |
| XareltoRivaroxaban | 19 | $16,031 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $13,023 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $9,519 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $5,841 |
| NexiumEsomeprazole Magnesium | 13 | $3,337 |
| SynthroidLevothyroxine Sodium | 23 | $1,433 |
| Atorvastatin Calcium | 68 | $758 |
| Duloxetine Hcl | 26 | $656 |
| Rosuvastatin Calcium | 73 | $590 |
| Levothyroxine Sodium | 54 | $545 |
| Metformin Hcl ErMetformin Hcl | 48 | $457 |
| Metformin Hcl | 47 | $417 |
| Omeprazole | 35 | $366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $753 | $35,44131 claims |
| Boehringer IngelheimJardiance, Synjardy | $118 | $27,76427 claims |
| Johnson & JohnsonXarelto | $100 | $16,03119 claims |
| AstraZenecaNexium | $240 | $3,33713 claims |
| AbbVieSynthroid | $732 | $1,43323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.
Other family in Blacksburg
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.